|
⚲
|
| Pike Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001884336 |
| Sale | 2026-06-30 ($0.8 M Offered, $0.8 M Sold) |
| Fund | |
| Phone | 4165096509 |
| Address | 20th Floor, 250 Howe Street Vancouver, A1 V6C 3R8 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-21 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Mark Purdy | Director | |
| Bradley Miles | Executive Officer | |
| Ian Fodie | Executive Officer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
North Growth Management Ltd
✚
|
A1 | 0.0 |
|
JPMorgan Asset Management Canada Inc
✚
|
A1 | 0.0 |
|
HSBC Global Asset Management Canada LTD
✚
|
A1 | 0.0 |
|
Dixon Mitchell Investment Counsel Inc
✚
|
A1 | 0.0 |
|
British Columbia Investment Management Corp
✚
|
A1 | 0.0 |
|
Genus Capital Management Inc
✚
|
A1 | 0.0 |
|
PenderFund Capital Management Ltd
✚
|
A1 | 0.0 |
|
Pacad Investment Ltd
✚
|
A1 | 0.0 |
|
Asia Pacific Associates III Ltd
✚
|
A1 | 0.0 |
|
McLean Budden Ltd
✚
|
A1 | 0.0 |